University of Washington Foundation
Seattle, Washington, United States
Purpose
to develop an injectable formulation of Tenofovir Alafenamide that could provide 6 – 12 months protection against HIV infection for low-income, at-risk women in low-resource settings
Division
Global Health
Date
October 2017
Region Served
AFRICA
Committed amount
$901,133
Grant topic
HIV
Duration (months)
33
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.